Technical Updates on Healthcare Sector Equities -- Cigna, Molina Healthcare, Humana, and Adeptus Health

Jun 29, 2016, 08:10 ET from Chelmsford Park SA

NEW YORK, June 29, 2016 /PRNewswire/ --

On Tuesday, June 28, 2016, the NASDAQ Composite ended the trading session at 4,691.87, up 2.12%; the Dow Jones Industrial Average advanced 1.57%, to finish at 17,409.72; and the S&P 500 closed at 2,036.09, up 1.78%. The gains were broad based as all the sectors ended the session in positive. has initiated coverage on the following equities: Cigna Corporation (NYSE: CI), Molina Healthcare Inc. (NYSE: MOH), Humana Inc. (NYSE: HUM), and Adeptus Health Inc. (NYSE: ADPT). Learn more about these stocks by accessing their free trade alerts at:

Bloomfield, Connecticut headquartered health services organization, Cigna Corp.'s stock finished Tuesday's session 2.56% higher at $125.21 with a total volume of 1.61 million shares traded. The stock is trading below its 50-day moving average by 4.85%. Cigna's stock traded at a PE ratio of 15.66 and has a Relative Strength Index (RSI) of 41.39. Sign up and read the free notes on CI at:

Molina Healthcare Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program. The stock advanced 1.47% to close the day at $49.74 with a total volume of 696,304 shares traded. The Company's shares have advanced 2.43% in the last one month. The stock is trading 3.67% below its 50-day moving average. Additionally, Molina Healthcare's stock traded at a PE ratio of 20.20 and has an RSI of 45.64. The complimentary notes on MOH can be downloaded in PDF format at:

On Tuesday, shares in Humana Inc. which together with its subsidiaries, operates as a health and well-being Company, recorded a trading volume of 2.64 million shares, which was higher than their three months average volume of 1.01 million shares. The stock ended the day 3.40% higher at $182.95. Shares of the Company traded at a PE ratio of 25.54. The Company's shares have advanced 5.30% in the last one month. The stock is trading above its 50-day and 200-day moving averages by 2.77% and 4.06%, respectively. Furthermore, shares of Humana have an RSI of 49.67. Register for free on and access the latest research on HUM at:

On Tuesday, shares in Adeptus Health Inc. which owns and operates a network of independent freestanding emergency rooms in the U.S., ended the session 1.61% higher at $49.28 with a total volume of 234,906 shares traded. Shares of the Company traded at a PE ratio of 34.49. The stock is trading 19.54% below its 50-day moving average. Moreover, shares of Adeptus Health have an RSI of 29.15. The Company was founded in 2002 and is based in Lewisville, Texas. Get free access to your trade alert on ADPT at:


Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number:  +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA